Wednesday, November 18, 2026 Editions
Latest
Trending
US

White House Drops Heidi Overton's FDA Nomination a Day Before Senate Committee Vote

The White House confirmed Tuesday that Dr. Heidi Overton will not lead the Food and Drug Administration, pulling her nomination after support collapsed on both sides of the Senate health committee.

Read inENESNEHIFR
White House Drops Heidi Overton's FDA Nomination a Day Before Senate Committee Vote
Photo: U.S. Food and Drug Administration, Public domain, via Wikimedia Commons (https://commons.wikimedia.org/wiki/File:FDA_Bldg_1_-_Exterior_With_Circle_(5161374950).jpg)

Key points

  • The White House is dropping Dr. Heidi Overton's nomination to lead the Food and Drug Administration, a White House official confirmed on Tuesday.
  • Overton is a physician and a deputy director of the White House Domestic Policy Council.
  • The committee, chaired by Senator Bill Cassidy of Louisiana, had set a Wednesday morning vote on Overton and on other pending nominees.

The White House is dropping Dr. Heidi Overton's nomination to lead the Food and Drug Administration, a White House official confirmed on Tuesday. The decision ends her bid one day before the Senate Health, Education, Labor and Pensions Committee was scheduled to vote on whether to advance her to the full Senate. Axios first reported the move. A senior administration official told Axios that Overton lacks the support on Capitol Hill to move forward with her confirmation.

Overton is a physician and a deputy director of the White House Domestic Policy Council. President Donald Trump picked her in August to run the FDA, the agency that approves drugs, vaccines and medical devices and polices food and tobacco products. She testified before the Senate health committee on September 24, 2026, as senators on both sides pressed her record.

The vote that will not happen

The committee, chaired by Senator Bill Cassidy of Louisiana, had set a Wednesday morning vote on Overton and on other pending nominees. Cassidy had questioned Overton's involvement in administration vaccine policies and stayed undecided about backing her ahead of the vote. In recent days, Trump officials worked to lock down support from a small group of senators, among them Susan Collins of Maine and Lisa Murkowski of Alaska, who support abortion rights, and Josh Hawley of Missouri, an abortion opponent, according to CNN. The effort did not hold. Without the votes to clear the committee, the White House moved first and pulled the nomination itself.

Pushback from both sides

Overton drew criticism from Democrats and Republicans alike. Opponents cited her alleged ties to the tobacco industry, her support for vaping products and her anti-abortion position, the New York Post reported. Her nomination also exposed a split between the Make America Healthy Again movement, led by Health and Human Services Secretary Robert F. Kennedy Jr., and more traditional conservative circles, CNN reported. Kennedy praised her nomination in August. People familiar with the working relationship between the two have described it as less than close. As a senior White House domestic policy adviser, Overton spent the past year and a half as a main link between HHS leaders pushing Make America Healthy Again policies and senior Trump officials who slowed several of those policies down, a role that built frustration on both sides.

The agency waits again

The FDA has had no permanent commissioner since Dr. Marty Makary stepped down in May. Kyle Diamantas is serving as acting commissioner, and he stays in that role while the administration looks for a new nominee. No replacement has been announced. Semafor reported that Republicans have discussed Senator Roger Marshall of Kansas, a physician who lost his reelection bid earlier this month, as a possible replacement. That discussion is reported talk inside the party, not a nomination, and the White House has named no one. The next pick inherits the same committee, the same split over vaccine policy, and an agency that has now gone more than six months without a confirmed leader.

Timeline

  1. Aug 2026President Trump picks Dr. Heidi Overton, a physician and deputy director of the White House Domestic Policy Council, to lead the FDA. Health and Human Services Secretary Robert F. Kennedy Jr. praises the nomination.
  2. Sep 24, 2026Overton testifies before the Senate Health, Education, Labor and Pensions Committee, where senators from both parties question her record.
  3. Nov 17, 2026The White House drops Overton's nomination, one day before the Senate health committee was scheduled to vote on advancing it.

Sources